314 results on '"Maratea, Dario"'
Search Results
2. Nephrotoxicity of Different Formulations of Amphotericin B: Summarizing Evidence by Network Meta-analysis
3. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine
4. First-line treatments for chronic lymphocytic leukaemia: interpreting efficacy data by network meta-analysis
5. Subcutaneous Biological Treatments for Moderate to Severe Psoriasis: Interpreting Safety Data by Network Meta-Analysis
6. Results can be summarised in a simple figure
7. Anti-reabsorptive agents in women with osteoporosis: determining statistical equivalence according to evidence-based methods
8. Biological Drugs for the Treatment of Moderate-to-Severe Psoriasis by Subcutaneous Route: Determining Statistical Equivalence According to Evidence-Based Methods
9. Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes
10. Acute lymphoblastic leukemia in first complete remission: temporal trend of outcomes in studies comparing allogeneic transplant with autologous transplant or chemotherapy
11. New and old anti-thrombotic treatments for patients with atrial fibrillation
12. Treatments for relapsing–remitting multiple sclerosis: summarising current information by network meta-analysis
13. Definizione di farmaco innovativo: rivisitazione in un contesto di risorse limitate
14. The Role of Bortezomib, Thalidomide and Lenalidomide in the Management of Multiple Myeloma: An Overview of Clinical and Economic Information
15. Un’esigenza di chiarezza: differenziare il payback “value-based” da quello non “value-based”
16. Rates of Inhibitor Development in Previously Untreated Patients with Severe Hemophilia A Treated with Plasma-Derived or Recombinant Factor VIII: No Proof of Difference or Proof of No Difference?
17. Sequential analysis shows that β blockade in non-cardiac surgery is ineffective and may even be harmful
18. Supplementation of n-3 polyunsaturated fatty acids to prevent postoperative atrial fibrillation in patients subjected to heart surgery
19. Omega-3 polyunsaturated fatty acids for patients at risk of sudden cardiac death and ventricular arrhythmias: Trial sequential analysis
20. The need to know crude event rates in meta-analysis
21. ω-3 Fatty Acid Supplements for Secondary Prevention of Cardiovascular Disease: From “No Proof of Effectiveness” to “Proof of No Effectiveness”
22. Erythropoiesis-stimulating agents in heart failure: no proof of effectiveness or proof of no effectiveness?
23. Mechanical endovascular therapy in ischaemic stroke: temporal trend of outcomes
24. Treatments for non-Hodgkin lymphoma in HIV-positive patients: Quantifying incremental benefit from 1993 to 2004 by metaregression
25. Between-Study Variability of Shortterm Mortality in Patients With Pararenal Aortic Pathologies Treated With Chimney or Fenestrated Endografts
26. Treatments for macular degeneration: summarising evidence using network meta-analysis
27. Viscosupplementation in patients with knee osteoarthritis: temporal trend of benefits assessed by meta-regression
28. Risk of intracranial haemorrhage in patients with atrial fibrillation treated with novel oral anticoagulants: testing the equivalence margins between dabigratran, rivaroxaban and apixaban
29. Temporal Trend of Overall Survival in Patients with Advanced Non-small Cell Lung Cancer Given First-Line Cytotoxic Treatments
30. Interpreting randomised trials evaluating newer agents or interferon in multiple sclerosis
31. Biological drugs for inducing remission in patients with Crohn's disease: determining statistical equivalence according to evidence-based methods
32. Comparing benefits expected in the design of randomized trials with the results of mature meta-analysis: An analysis on aspiration thrombectomy in acute myocardial infarction
33. Risk of Myocardial Infarction With Oral Direct Thrombin Inhibitors: Trial Sequential Analysis Based on Two Published Data Sets
34. Long-term outcomes in chronic obstructive pulmonary disease patients: exploring the effects of inhalatory devices and their influence on the outcome
35. Effectiveness of drug-eluting balloons: Quantifying the information size from clinical trials
36. Intra-aortic balloon pump in high-risk percutaneous coronary interventions without cardiogenic shock: Trial sequential analysis of outcomes
37. All-Cause Mortality in Patients With Unprotected Left Main Coronary Disease: Comparison Between Stenting and Coronary Artery Bypass Grafting
38. The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
39. Early market access for unauthorized drugs in Italy: The value-based price for reimbursement decisions
40. Long-term outcomes in chronic obstructive pulmonary disease patients: exploring the effects of inhalatory devices and their influence on the outcome
41. Producing evidence in support of disinvestment: The experience of the Tuscany region in Italy
42. Economic analysis of not running tenders for recombinant Factor VIII procurement: a simplified analysis to estimate an otherwise unknown pharmacoeconomic index
43. Bayesian network meta-analysis to evaluate interferon-free treatments in naive patients with genotype 1 hepatitis C virus infection
44. Comparative effectiveness of treatments for newly diagnosed follicular non-Hodgkin lymphoma
45. Testing the therapeutic equivalence of novel oral anticoagulants for thromboprophylaxis in orthopedic surgery and for prevention of stroke in atrial fibrillation
46. Second-line treatments for advanced gastric cancer: Interpreting outcomes by network meta-analysis
47. Letter to the Editor Biological drugs for inducing remission in patients with Crohn’s disease: determining statistical equivalence according to evidence-based methods
48. Indirect meta-analytical comparison of azathioprine and of beta interferon effectiveness in all forms of multiple sclerosis pooled together
49. Anti-platelet treatments in acute coronary syndrome: Simplified network meta-analysis
50. Biological drugs for the treatment of rheumatoid arthritis by the subcutaneous route: interpreting efficacy data to assess statistical equivalence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.